Retinoids Market

By Type;

Natural Retinoids and Synthetic Retinoids

By Form Type;

Cream, Gel, and Liquid

By Distribution Channel;

Hospital Pharmacies, Retail Pharmacies, E-commerce, and Others

By Application;

Acne, Psoriasis, Anti-aging, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn113079382 Published Date: August, 2025

Retinoids Market Overview

Retinoids Market (USD Million)

Retinoids Market was valued at USD 1,660.67 million in the year 2024. The size of this market is expected to increase to USD 2,391.17 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.


Retinoids Market

*Market size in USD million

CAGR 5.3 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.3 %
Market Size (2024)USD 1,660.67 Million
Market Size (2031)USD 2,391.17 Million
Market ConcentrationMedium
Report Pages397
1,660.67
2024
2,391.17
2031

Major Players

  • GlaxoSmithKline Inc.
  • Mylan Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Ortho Dermatologics

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Retinoids Market

Fragmented - Highly competitive market without dominant players


The Retinoids Market is growing steadily as their use expands across dermatology and ophthalmology. Nearly 35% of skincare treatments now incorporate retinoids for concerns like acne and aging. Their role in managing retinal diseases is also becoming more prominent. Consumers and providers recognize their dual value for both aesthetic and medical outcomes.

Collaborations Driving Product Expansion
Close to 40% of new launches are backed by joint efforts between pharmaceutical developers and cosmetic companies. These partnerships enhance formulation design, branding, and market penetration. Collaborators are targeting new delivery routes and compound variations. Expansion is supported through shared R&D, licensing, and commercial rollout.

Clean Formulas and Sustainability Rising
Around 25% of manufacturers are adopting plant-based retinoids, biodegradable containers, and minimalist labels. Consumer preference for eco-friendly and clean formulations is guiding product development. Brands are aligning with green values and updated regulatory frameworks. These choices are opening new marketing opportunities.

Diversified Portfolios Supporting Growth
More than 45% of companies are expanding into global markets with targeted offerings across clinical and consumer channels. Strategies include licensing deals, direct-to-consumer portals, and ophthalmic-specific applications. Next-gen analogs and enhanced formulations are driving differentiation. The future outlook is focused on innovation, access, and specialized delivery.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type

    2. Market Snapshot, By Form Type
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Application
    5. Market Snapshot, By Region
  4. Retinoids Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising skincare awareness
        2. Increasing aging population
        3. Growing dermatology treatments
        4. Expanding product innovations
        5. Celebrity endorsements trend
      2. Restraints
        1. High product costs
        2. Potential side effects
        3. Stringent regulatory approvals
        4. Limited product availability
        5. Lack of awareness
      3. Opportunities
        1. Emerging market potential
        2. Product diversification scope
        3. Increasing online sales
        4. Advancements in formulations
        5. Expanding consumer base
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Commpetitive Rivalry
  5. Market Segmentation
    1. Retinoids Market,By Type, 2021 - 2031 (USD Million)
      1. Natural Retinoids

      2. Synthetic Retinoids

    2. Retinoids Market,By Form Type, 2021 - 2031 (USD Million)
      1. Cream
      2. Gel
      3. Liquid
    3. Retinoids Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. E-Commerce
      4. Others
    4. Retinoids Market,By Form Application, 2021 - 2031 (USD Million)
      1. Acne
      2. Psoriasis
      3. Anti-aging
      4. Others
    5. Retinoids Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Latin America

        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
      5. Middle East & Africa

        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
  6. Competitive Landscape
    1. Company Profiles
      1. GlaxoSmithKline Inc.
      2. Mylan Pharmaceuticals Inc.
      3. Sun Pharmaceutical Industries Ltd.
      4. Janssen Pharmaceuticals Inc.
      5. Bausch Health Companies Inc.
      6. Ortho Dermatologics
  7. Analyst Views
  8. Future Outlook of the Market